Zeronda Tyler — SEC insider filings
SEC reporting owner CIK 1867033. 30 insider filings on record with FilingPulse; latest filed 2026-10-30.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2021-07-02 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | Chief Financial Officer | 30 | — | — | 35 |
Insider filings — Zeronda Tyler
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-30 | 4 | Yarrow Bioscience, Inc. (YARW) | Grant/award (A): 156,115 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | Yarrow Bioscience, Inc. (YARW) | Grant/award (A): 185,798 (derivative) @ $0 | EDGAR |
| 2026-07-24 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 22,516 @ $0.90 | EDGAR |
| 2026-07-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 3,464 @ $0.65 | EDGAR |
| 2026-04-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 4,007 @ $0.60 | EDGAR |
| 2026-01-05 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 7,858 @ $0.58 | EDGAR |
| 2025-10-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 3,420 @ $0.34 | EDGAR |
| 2025-07-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 3,420 @ $1.65 | EDGAR |
| 2025-04-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 8,399 @ $1.58 | EDGAR |
| 2025-01-23 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 230,000 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 4,675 @ $3.35 | EDGAR |
| 2024-10-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 84 @ $1.88 | EDGAR |
| 2024-07-03 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 92 @ $1.92 | EDGAR |
| 2024-04-03 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 94 @ $3.08 | EDGAR |
| 2024-01-03 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 62,500 @ $0 · Tax withholding (F): 93 @ $2.28 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 62,500 @ $0 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2023-10-04 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 1,087 @ $3.83 | EDGAR |
| 2023-07-05 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 91 @ $4.10 | EDGAR |
| 2023-04-04 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 384 @ $3.08 | EDGAR |
| 2023-01-04 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 354 @ $0.15 | EDGAR |
| 2022-10-04 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 353 @ $0.22 | EDGAR |
| 2022-07-05 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 354 @ $0.39 | EDGAR |
| 2022-06-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 12,510 @ $0.35 | EDGAR |
| 2022-04-04 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 773 @ $0.65 | EDGAR |
| 2022-03-18 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 75,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 206 @ $1.02 | EDGAR |
| 2021-12-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 4,187 @ $0.88 | EDGAR |
| 2021-10-01 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 206 @ $1.39 | EDGAR |
| 2021-09-03 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 60,859 @ $0 · Grant/award (A): 60,860 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 700 @ $3.51 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-07-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1867033 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs